# EDGAR Filing Document

**Accession Number:** 0001469443
**File Stem:** 0001193125-26-025264
**Filing Date:** 2026-1
**Character Count:** 2277
**Document Hash:** da549310a21f016949d309379d790acf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-025264.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001193125-26-025264

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Arcadia Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0001469443
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 810571538
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 2000
- **CITY:** DALLAS
- **STATE:** TX
- **BUSINESS PHONE:** 214-974-8921

**MAIL ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 2000
- **CITY:** DALLAS
- **STATE:** TX

January 27, 2026

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Attn: Filing Desk

**Re: Arcadia Biosciences, Inc.**

**Registration Statement on Form S-3**

Ladies and Gentlemen:

On behalf of Arcadia Biosciences, Inc. (the "Company"), we submit for filing under the Securities Act of 1933, as amended (the "Act"), a Registration Statement on Form S-3 covering the possible resale by certain selling shareholders of shares of the Company's Common Stock, pursuant to Rule 415 of the Act, together with certain exhibits thereto. The Company's common stock is listed on the Nasdaq Capital Market.

This filing is being effected by EDGAR. Please note that the Company has wired the filing fee to the account of the Securities and Exchange Commission. T

Please call the undersigned at (916) 558-6110, or email the undersigned at kkelso@weintraub.com, with any questions or comments.

WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN

Law Corporation

/s/ C. Kevin Kelso

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. Kevin Kelso

------